ALDEYRA THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
ALDEYRA THERAPEUTICS, INC. (ALDX) reported Other Comprehensive Income (Loss), Net of Tax of -$37.44 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-02-27
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-06-30 was -$6.63K.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2024-03-31 was -$3.03K, a 102.91% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2025 was -$37.44K.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2023 was $103.94K.
- ALDEYRA THERAPEUTICS, INC. other comprehensive income (loss), net of tax for fiscal 2022 was -$103.94K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$37.44K 10-K · filed 2026-02-27 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 | |||
| 2024-06-30 | -$6.63K 10-Q · filed 2024-08-01 | -$9.66K 10-Q · filed 2024-08-01 | -$9.66K derived: sum of 3 quarters · filed 2025-02-28 | -$9.66K derived: sum of 4 quarters · filed 2025-02-28 |
| 2024-03-31 | -$3.03K 10-Q · filed 2024-05-02 | -$3.03K derived: sum of 2 quarters · filed 2025-02-28 | -$3.03K derived: sum of 3 quarters · filed 2025-02-28 | -$3.03K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $103.94K 10-K · filed 2025-02-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $103.94K 10-Q · filed 2024-11-07 | $285.73K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $103.94K 10-Q · filed 2024-08-01 | $285.73K derived: sum of 3 quarters · filed 2024-08-01 | $285.76K derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $103.94K 10-Q · filed 2024-05-02 | $285.73K derived: sum of 2 quarters · filed 2024-05-02 | $285.76K derived: sum of 3 quarters · filed 2024-05-02 | $61.68K derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $181.79K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $181.82K derived: sum of 2 quarters · filed 2024-03-07 | -$42.26K derived: sum of 3 quarters · filed 2024-03-07 | -$103.94K 10-K · filed 2024-03-07 |
| 2022-09-30 | $30.00 10-Q · filed 2023-11-03 | -$224.06K derived: sum of 2 quarters · filed 2023-11-03 | -$285.73K 10-Q · filed 2023-11-03 | |
| 2022-06-30 | -$224.09K 10-Q · filed 2023-08-03 | -$285.76K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$61.68K 10-Q · filed 2023-05-04 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$4.75K derived: sum of 2 quarters · filed 2022-03-17 | -$57.59K derived: sum of 3 quarters · filed 2022-03-17 | -$5.87K 10-K · filed 2022-03-17 |
| 2020-09-30 | -$4.75K 10-Q · filed 2021-10-28 | -$57.59K derived: sum of 2 quarters · filed 2021-10-28 | -$5.87K 10-Q · filed 2021-10-28 | -$5.77K derived: sum of 4 quarters · filed 2021-10-28 |
| 2020-06-30 | -$52.84K 10-Q · filed 2021-08-05 | -$1.11K 10-Q · filed 2021-08-05 | -$1.01K derived: sum of 3 quarters · filed 2021-08-05 | -$8.70K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $51.73K 10-Q · filed 2021-05-06 | $51.83K derived: sum of 2 quarters · filed 2021-05-06 | $44.14K derived: sum of 3 quarters · filed 2021-05-06 | $50.78K derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $100.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$7.59K derived: sum of 2 quarters · filed 2021-03-11 | -$946.00 derived: sum of 3 quarters · filed 2021-03-11 | $15.09K 10-K · filed 2021-03-11 |
| 2019-09-30 | -$7.69K 10-Q · filed 2020-11-05 | -$1.05K derived: sum of 2 quarters · filed 2020-11-05 | $14.99K 10-Q · filed 2020-11-05 | $10.96K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $6.64K 10-Q · filed 2020-08-06 | $22.68K 10-Q · filed 2020-08-06 | $18.65K derived: sum of 3 quarters · filed 2020-08-06 | $16.01K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $16.04K 10-Q · filed 2020-05-07 | $12.01K derived: sum of 2 quarters · filed 2020-05-07 | $9.37K derived: sum of 3 quarters · filed 2020-05-07 | $23.20K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$4.03K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$6.67K derived: sum of 2 quarters · filed 2020-03-12 | $7.16K derived: sum of 3 quarters · filed 2020-03-12 | $8.61K 10-K · filed 2020-03-12 |
| 2018-09-30 | -$2.64K 10-Q · filed 2019-11-07 | $11.19K derived: sum of 2 quarters · filed 2019-11-07 | $12.63K 10-Q · filed 2019-11-07 | -$4.19K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $13.83K 10-Q · filed 2019-08-09 | $15.27K 10-Q · filed 2019-08-09 | -$1.56K derived: sum of 3 quarters · filed 2019-08-09 | $2.08K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $1.45K 10-Q · filed 2019-05-10 | -$15.38K derived: sum of 2 quarters · filed 2019-05-10 | -$11.74K derived: sum of 3 quarters · filed 2019-05-10 | -$11.64K derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | -$16.83K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$13.19K derived: sum of 2 quarters · filed 2019-03-08 | -$13.08K derived: sum of 3 quarters · filed 2019-03-08 | -$17.96K 10-K · filed 2019-03-08 |
| 2017-09-30 | $3.64K 10-Q · filed 2018-11-14 | $3.75K derived: sum of 2 quarters · filed 2018-11-14 | -$1.13K 10-Q · filed 2018-11-14 | -$7.53K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $107.00 10-Q · filed 2018-08-09 | -$4.77K 10-Q · filed 2018-08-09 | -$11.17K derived: sum of 3 quarters · filed 2018-08-09 | -$9.34K derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | -$4.88K 10-Q · filed 2018-05-15 | -$11.28K derived: sum of 2 quarters · filed 2018-03-29 | -$9.45K derived: sum of 3 quarters · filed 2018-03-29 | -$6.55K derived: sum of 4 quarters · filed 2018-03-29 |
| 2016-12-31 | -$6.40K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$4.57K derived: sum of 2 quarters · filed 2018-03-29 | -$1.67K derived: sum of 3 quarters · filed 2018-03-29 | $8.49K 10-K · filed 2018-03-29 |
| 2016-09-30 | $1.82K 10-Q · filed 2017-11-09 | $4.73K derived: sum of 2 quarters · filed 2017-11-09 | $14.89K 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $2.90K 10-Q · filed 2017-08-07 | $13.06K 10-Q · filed 2017-08-07 | ||
| 2016-03-31 | $10.16K 10-Q · filed 2017-05-15 | |||
| 2015-12-31 | -$8.36K 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |